BCR-ABL1-话题@MedSci

#BCR-ABL1#

10篇内容 | 681人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1956485, encodeId=b0ce195648535, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=BCR-ABL1融合基因阳性急性淋巴细胞白血病的那些小秘密, objectType=article, longId=732594, objectId=9881e3259437, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9881e3259437, replyNumber=0, likeNumber=62, createdTime=2023-01-03, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9881e3259437, moduleTitle=BCR-ABL1融合基因阳性急性淋巴细胞白血病的那些小秘密, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9881e3259437)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956484, encodeId=882719564845c, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=Blood：分子分类可改善BCR-ABL1阴性B-ALL成人患者的风险评估, objectType=article, longId=217625, objectId=ef7421e625f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef7421e625f6, replyNumber=0, likeNumber=40, createdTime=2021-11-16, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef7421e625f6, moduleTitle=Blood：分子分类可改善BCR-ABL1阴性B-ALL成人患者的风险评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef7421e625f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956483, encodeId=5410195648321, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=CLIN CHEM LAB MED：拉丁美洲CML患者BCR-ABL1量化方案？, objectType=article, longId=203922, objectId=2da2203922c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2da2203922c1, replyNumber=0, likeNumber=0, createdTime=2021-10-22, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2da2203922c1, moduleTitle=CLIN CHEM LAB MED：拉丁美洲CML患者BCR-ABL1量化方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2da2203922c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956482, encodeId=8f171956482cc, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=Blood：BCR-ABL1早期动力学可预测CML无治疗缓解的长期预后, objectType=article, longId=200652, objectId=9d89200652e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d89200652e5, replyNumber=0, likeNumber=31, createdTime=2020-12-19, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d89200652e5, moduleTitle=Blood：BCR-ABL1早期动力学可预测CML无治疗缓解的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d89200652e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956480, encodeId=bcde1956480e7, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=BCR-ABL1阳性变异型毛细胞白血病1例, objectType=article, longId=194502, objectId=a13e19450206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a13e19450206, replyNumber=0, likeNumber=39, createdTime=2021-04-21, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a13e19450206, moduleTitle=BCR-ABL1阳性变异型毛细胞白血病1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a13e19450206)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956481, encodeId=c8b819564812b, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=CLIN CHEM LAB MED：比较外周血和骨髓中BCR-ABL1？, objectType=article, longId=198758, objectId=0661198e58ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0661198e58ab, replyNumber=0, likeNumber=50, createdTime=2020-11-03, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0661198e58ab, moduleTitle=CLIN CHEM LAB MED：比较外周血和骨髓中BCR-ABL1？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0661198e58ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956479, encodeId=adff19564e955, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=Blood：用二代测序筛查慢性髓系白血病BCR-ABL1突变, objectType=article, longId=185327, objectId=c85818532e81, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c85818532e81, replyNumber=0, likeNumber=37, createdTime=2020-10-30, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c85818532e81, moduleTitle=Blood：用二代测序筛查慢性髓系白血病BCR-ABL1突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c85818532e81)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956477, encodeId=7bf919564e78b, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=Haematologica：病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, objectType=article, longId=160125, objectId=f00f160125bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f00f160125bf, replyNumber=0, likeNumber=44, createdTime=2019-11-15, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f00f160125bf, moduleTitle=Haematologica：病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f00f160125bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956478, encodeId=436d19564e806, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, objectType=article, longId=160191, objectId=ae36160191ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae36160191ca, replyNumber=0, likeNumber=45, createdTime=2019-07-12, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae36160191ca, moduleTitle=病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae36160191ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956476, encodeId=508419564e644, content=<a href='/topic/show?id=002d32834b' target=_blank style='color:#2F92EE;'>#BCR-ABL1#</a>, objectTitle=Blood：血栓性微血管病变是BCR-ABL1酪氨酸激酶抑制剂帕纳替尼引发心血管毒性的原因之一, objectType=article, longId=159627, objectId=aaa415962ed1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaa415962ed1, replyNumber=0, likeNumber=44, createdTime=2019-05-10, rootId=0, userName=12498717m66(暂无昵称), userId=951d2500061, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaa415962ed1, moduleTitle=Blood：血栓性微血管病变是BCR-ABL1酪氨酸激酶抑制剂帕纳替尼引发心血管毒性的原因之一, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaa415962ed1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

BCR-ABL1

2020-05-29

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

BCR-ABL1融合基因阳性急性淋巴细胞白血病的那些小秘密

2023-01-03

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

Blood：分子分类可改善BCR-ABL1阴性B-ALL成人患者的风险评估

2021-11-16

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

CLIN CHEM LAB MED：拉丁美洲CML患者BCR-ABL1量化方案？

2021-10-22

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

Blood：BCR-ABL1早期动力学可预测CML无治疗缓解的长期预后

2020-12-19

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

BCR-ABL1阳性变异型毛细胞白血病1例

2021-04-21

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

CLIN CHEM LAB MED：比较外周血和骨髓中BCR-ABL1？

2020-11-03

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

Blood：用二代测序筛查慢性髓系白血病BCR-ABL1突变

2020-10-30

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

Haematologica：病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1

2019-11-15

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

病例分享 | 慢性髓系白血病双费城染色体阳性同时表达P210BCR-ABL1和P195BCR-ABL1

2019-07-12

12498717m66(暂无昵称) (审核中...)

前往app查看评论内容

#BCR-ABL1#

Blood：血栓性微血管病变是BCR-ABL1酪氨酸激酶抑制剂帕纳替尼引发心血管毒性的原因之一

2019-05-10

科室
- - 订阅+
  - 更多科室
工具
服务